COMMUNIQUÉS West-GlobeNewswire

The improved decisions of Latvijas Juras medicinas centrs JSC Annual Shareholders’ Meeting on June, 12, 2018.
14/06/2018
Latvia, 2018-06-14 08:24 CEST (GLOBE NEWSWIRE) -- The improved decisions of Latvijas Juras medicinas centrs JSC Annual Shareholders’ Meeting on June, 12, 2018. Information about Ex-date is added to p.2. of the decision [...]
Fermion's new plant operational in Hanko - nearly 100% of production is exported
14/06/2018
Orion Corporation Press release 14 June 2018 at 9.00 a.m. Fermion's new plant operational in Hanko - nearly 100% of production is exported Fermion Oy, which manufactures active pharmaceutical ingredients (APIs) for the [...]
Shire plc : Rule 2.9 Announcement
14/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 14 June 2018 Shire [...]
Motif Bio Submits NDA for Iclaprim
14/06/2018
NEW YORK, June 14, 2018 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM:MTFB) (NASDAQ:MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced the completion of its rolling [...]
Bone Therapeutics SA announces results of Annual General Meeting
14/06/2018
Press release Bone Therapeutics announces results of Annual General Meeting Company reshapes and strengthens its Board of Directors with focus on improving governance and diversity Additional Extraordinary Shareholders [...]
Bone Therapeutics SA annonce les résultats de l'Assemblée Générale Ordinaire du 13 juin 2018
14/06/2018
Communiqué de presse Bone Therapeutics annonce les résultats de l'Assemblée Générale Ordinaire du 13 juin 2018 Renforcement de la gouvernance et de la diversité au sein du Conseil d'administration Organisation d'une [...]
argenx announces data from Phase 1 study of efgartigimod (ARGX-113) subcutaneous formulation demonstrating comparable characteristics to intravenous formulation
14/06/2018
- Subcutaneous formulation offers potential for increased patient convenience and acceptance - June 14, 2018 Breda, the Netherlands/Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology [...]
Agility Health Announces Management Cease Trade Order Update
14/06/2018
GRAND RAPIDS, Mich., June 13, 2018 (GLOBE NEWSWIRE) -- Agility Health, Inc. (TSXV:AHI) (“ Agility Health ” or the “ Corporation ”), a leading provider of orthotics, prosthetics and foot care services in Canada, is [...]
Innovate Biopharmaceuticals Announces Appointment of Saira Ramasastry to Board of Directors and Resignation of Anna Kazanchyan, M.D.
14/06/2018
RALEIGH, N.C., June 13, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq:INNT), a clinical stage biotechnology company focused on developing novel therapeutics for immuno-inflammatory [...]
New England Journal of Medicine Publishes Novavax’ NanoFlu Clinical Trial Data
13/06/2018
NanoFlu TM Phase 1/2 trial data published in a peer-reviewed letter to the editor in The New England Journal of Medicine NanoFlu demonstrates significantly improved immune responses against a panel of homologous and [...]
Teligent, Inc. Announces FDA Approval of Diflorasone Diacetate Ointment 0.05%
13/06/2018
BUENA, N.J., June 13, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]
Clearside Biomedical Announces Completion of Patient Enrollment in First of Two Phase 3 Clinical Trials of CLS-TA in Retinal Vein Occlusion
13/06/2018
ALPHARETTA, Ga., June 13, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
AIT Therapeutics Reports Positive Top Line Results from its Nitric Oxide in Bronchiolitis (NO-BRO) Pilot Study in Infants
13/06/2018
Pivotal study expected to commence in the fourth quarter of calendar year 2019 NEW YORK, June 13, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTC:AITB), a clinical-stage medical device and biopharmaceutical company [...]
Globus Medical Launches Cement Augmented Pedicle Screw System
13/06/2018
AUDUBON, Pa., June 13, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the launch of the CREO® Fenestrated Screw System used in the treatment of [...]
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2018 Financial Results
13/06/2018
Strong Annual Year-Over-Year Growth in Revenue of 30% $10 Million in Cash as of March 31, 2018 Conference Call Begins at 4:30pm EDT Today PETALUMA, Calif., June 13, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc [...]
Melinta Therapeutics to Present at the JMP Securities Life Sciences Conference
13/06/2018
NEW HAVEN, Conn., June 13, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial [...]
K2M Group Holdings, Inc. Announces Private Offering of $65.0 Million Aggregate Principal Amount of Convertible Senior Notes due 2025
13/06/2018
LEESBURG, Va., June 13, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (Nasdaq:KTWO) (“K2M”) today announced that it intends to offer, subject to market and other conditions, $65.0 million aggregate principal amount [...]
Harvard Bioscience Subsidiary Data Sciences International Launches Inhalation Exposure System
13/06/2018
A Platform Designed by Pulmonary Experts to Provide Accurate, Real-Time Monitoring of Respiratory Endpoints ST. PAUL, Minn. and HOLLISTON, Mass., June 13, 2018 (GLOBE NEWSWIRE) -- Data Sciences International (DSI), a [...]
Cytokinetics to Present at the JMP Securities Life Sciences Conference
13/06/2018
SOUTH SAN FRANCISCO, Calif., June 13, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq:CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to present a corporate update at [...]

Pages